登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603285 证券简称：键邦股份 公告编号：2025-053 山东键邦新材料股份有限公司 ■ 二、公司前十大无限售条件股东持股情况 ■ 特此公告。 山东键邦新材料股份有限公司 关于回购股份事项前十大股东和 前十大无限售条件股东持股情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 山东键邦新材料股份有限公司（以下简称"公司"）于2025年11月28日召开第二届董事会第十一次会议， 审议通过了《关于以集中竞价方式回购股份的议案》，具体内容详见公司于2025年11月29日在上海证券 交易所（www.sse.com.cn）等指定信息披露媒体披露的《山东键邦新材料股份有限公司关于以集中竞价 方式回购股份的预案》（公告编号：2025-052）。 根据《上海证券交易所上市公司自律监管指引第7号一一回购股份》等相关法律法规规定，现将董事会 公告回购股份决议的前一个交易日（即2025年11月28日）登记在册的前十大股东和前十大无限售条件股 东的名称、持股数量及持股比例情况公告 ...

证券代码：688599 证券简称：天合光能 公告编号：2025-116 转债代码：118031 转债简称：天23转债 天合光能股份有限公司 关于以集中竞价交易方式回购公司股份 的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ■ 登录新浪财经APP 搜索【信披】查看更多考评等级 一、回购股份的基本情况 2024年6月25日，公司召开第三届董事会第七次会议，审议通过了《关于以集中竞价交易方式回购公司 股份方案的议案》，同意公司以自有资金通过集中竞价交易方式回购公司无限售条件的A股流通股。回 购股份将用于转换公司发行的可转换为股票的公司债券，回购价格不超过人民币31.00元/股（含），回 购资金总额不低于人民币100,000万元（含），不超过人民币120,000万元（含）,回购期限自公司董事会 审议通过回购方案之日起12个月内。具体内容详见公司于2024年6月26日在上海证券交易所网站 （www.sse.com.cn）披露的《天合光能股份有限公司关于以集中竞价交易方式回购股份的回购报告书》 （公告编号：2 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 一、公司控股股东本次股份质押情况 公司于2025年12月2日获悉广汇集团所持本公司部分股份被质押，具体情况如下： 1.本次股份质押基本情况 证券代码：600603 证券简称：广汇物流（维权） 公告编号：2025-088 广汇物流股份有限公司 关于控股股东部分股份质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 广汇物流股份有限公司（以下简称"公司"）控股股东新疆广汇实业投资（集团）有限责任公司（以下 简称"广汇集团"）及其一致行动人新疆广汇化工建材有限责任公司（以下简称"广汇化建"）共持有公司 股份601,297,829股，占公司总股本1,193,329,151股的50.39%。本次质押后，累计质押数量379,952,400 股，占其所持有公司股份总数的63.19%，占公司总股本的31.84%。 ■ 2.本次质押登记手续已在中国证券登记结算有限责任公司办理完成，本次质押股份不涉及重大资产重组 业绩补偿等事项的担保和其他保障用途。 3.股东累计质押股 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603861 证券简称：白云电器 公告编号：2025-101 广州白云电器设备股份有限公司 二、回购股份的进展情况 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第7号一一回购股份》等相关 规定，在回购股份期间，上市公司应当在每个月的前3个交易日内，公告截至上月末的回购进展情况。 现将公司回购股份的进展情况公告如下： 截至2025年11月30日，公司通过上海证券交易所交易系统以集中竞价交易方式累计回购股份86,500股， 已回购股份占公司总股本540,527,955股的比例为0.0160%，回购成交的最高价为11.60元/股，最低价为 11.60元/股，成交总金额为人民币100.34万元（不含交易费用）。 上述回购股份符合法律法规的规定及公司回购股份方案的要求。 三、其他事项 关于回购公司股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ■ 一、回购股份的基本情况 2025年8月1日，公司召开第七届董事会第十九次会议、第 ...

Core Viewpoint - The announcement details the completion of the third vesting period for the 2022 restricted stock incentive plan of Shenzhen Yingjixin Technology Co., Ltd, with shares set to be listed on December 8, 2025 [2][12]. Group 1: Incentive Plan Details - The stock listing date for the incentive plan is December 8, 2025 [2]. - The total number of shares listed for circulation is 3,302,894 shares [4][12]. - The incentive plan has undergone necessary decision-making procedures and disclosures, including board and supervisory meetings [3][5]. Group 2: Shareholder Meetings and Approvals - The first extraordinary general meeting of shareholders in 2022 approved the incentive plan and related proposals [4][5]. - Subsequent meetings in 2023 and 2024 continued to review and approve adjustments to the incentive plan, including vesting conditions and share price adjustments [6][7][8]. Group 3: Stock Vesting and Distribution - A total of 195 individuals are designated as incentive recipients for the third vesting period [12]. - The shares for this vesting period are sourced from the company's issuance of A-shares to the incentive recipients [12]. Group 4: Financial Impact - The newly vested shares represent approximately 0.77% of the total shares before vesting, with no significant impact on the company's recent financial performance [15].

| 日期 | 回购股数 | 回购最高价 | 回购最低价 | 回购金额 | | --- | --- | --- | --- | --- | | | （万股） | （港元） | （港元） | （万港元） | | 2025.12.02 | 300.00 | 13.810 | 13.620 | 4105.30 | | 2025.12.01 | 94.50 | 13.620 | 13.240 | 1276.19 | | 2025.11.28 | 300.00 | 13.370 | 13.220 | 3978.25 | | 2025.11.27 | 141.00 | 13.350 | 13.180 | 1870.22 | | 2025.11.26 | 300.00 | 13.460 | 13.250 | 3993.31 | | 2025.11.25 | 300.00 | 13.480 | 13.380 | 4030.37 | | 2025.11.24 | 300.00 | 13.560 | 13.410 | 4035.00 | | 2025.11.21 | 300.00 | 13.630 | 13.430 | 4058. ...

自10月24日以来公司已连续27日进行回购，合计回购1.93亿股，累计回购金额8.24亿港元。 其间该股累 计上涨4.48%。 （原标题：中国飞鹤(06186.HK)连续27日回购，累计回购1.93亿股） 证券时报•数据宝统计，中国飞鹤在港交所公告显示，12月2日以每股4.170港元至4.200港元的价格回购 400.00万股，回购金额达1674.00万港元。该股当日收盘价4.200港元，平盘报收，全天成交额7219.58万 港元。 中国飞鹤回购明细 | 日期 | 回购股数 | 回购最高价 | 回购最低价 | 回购金额 | | --- | --- | --- | --- | --- | | | （万股） | （港元） | （港元） | （万港元） | | 2025.12.02 | 400.00 | 4.200 | 4.170 | 1674.00 | | 2025.12.01 | 150.00 | 4.230 | 4.190 | 631.65 | | 2025.11.28 | 230.00 | 4.220 | 4.150 | 958.58 | | 2025.11.27 | 400.00 | 4.230 | 4. ...

Core Viewpoint - Longbai Group has made significant progress in its share repurchase plan, having repurchased shares worth approximately 25.48 million yuan as of November 30, 2025, which aligns with its established plan and regulatory requirements [1][3]. Summary by Sections Share Repurchase Plan Overview - On June 6, 2025, Longbai Group's board approved a share repurchase plan, intending to use its own funds and special loans to repurchase A-shares for employee stock ownership plans [2]. - The plan has a total funding range of 5 billion yuan to 10 billion yuan, with a maximum repurchase price set at 24.32 yuan per share, and is to be executed within 12 months from the board's approval [2]. Progress of Share Repurchase - As of November 30, 2025, Longbai Group has repurchased shares at a minimum price of 16.18 yuan per share, totaling approximately 25.48 million yuan (excluding transaction fees) [3]. - The repurchase is in compliance with relevant regulations and aligns with the company's established repurchase plan [3]. Compliance and Regulatory Adherence - Longbai Group emphasizes strict adherence to regulatory requirements during the share repurchase, ensuring that repurchases do not occur during periods that could significantly impact stock prices [4]. - The company has complied with trading regulations, ensuring that the repurchase prices were not set at the daily trading limit and did not occur during restricted trading periods [4]. Future Plans - The company plans to continue its share repurchase efforts within the 12-month timeframe, adjusting based on market conditions and operational performance [5]. - Longbai Group has utilized approximately 5.1% of the lower limit of the repurchase funds (based on the 5 billion yuan minimum) and will maintain transparency in its repurchase process [5].

Group 1 - The company announced a stock repurchase plan, intending to buy back 10.3147 million A-shares, which represents 1.0015% of the total share capital [1] - The maximum transaction price for the repurchased A-shares is set at 7.45 yuan per share, while the minimum price is 6.58 yuan per share [1] - The total amount allocated for this stock repurchase is 72.6306 million yuan, excluding transaction fees [1]

Core Viewpoint - The company, Giant Bio (02367.HK), has announced a large-scale share buyback plan, which has positively impacted its stock price and market perception, reflecting investor confidence in its future development [1][9]. Company Performance - Giant Bio is a leading player in the recombinant collagen market, with its products being widely used in popular beauty products. The company has been recognized as a global leader in recombinant collagen by authoritative market research institutions [2][10]. - For the first half of the year, Giant Bio reported a revenue of 31.13 billion RMB, a year-on-year increase of 22.5%. Gross profit was 25.42 billion RMB, up 21.5%, and net profit reached 11.82 billion RMB, growing by 20.6% [2][10]. Stock Price Dynamics - Since May, the stock price of Giant Bio has been on a downward trend, losing nearly half of its value from its peak. This decline was partly due to negative publicity regarding the collagen content in its products, leading to a public relations crisis [3][11]. - The company's brand, Kefu Mei, experienced a decline in GMV during the Double Eleven shopping festival, raising concerns about consumer acceptance and impacting the stock price further [3][11]. Share Buyback Plan - In response to the stock price decline, Giant Bio announced a buyback plan to repurchase up to approximately 104 million shares, representing 10% of its total issued shares. This move is seen as a sign of management's confidence in the company's intrinsic value and commitment to optimizing capital structure [4][12]. - Large-scale buybacks are typically viewed as a signal that a company's stock is undervalued and indicate strong cash flow and stable operations [6][14]. Market Outlook - Despite current challenges in the consumer market, Giant Bio is considered competitive in product development, channel construction, and brand building. The buyback action is expected to enhance market perception of its operational stability and long-term growth potential [6][14]. - Analysts remain optimistic about the company's future performance, projecting net profits of 24.3 billion RMB, 29.8 billion RMB, and 36.4 billion RMB for 2025-2027, with corresponding P/E ratios of 15X, 12X, and 10X [15].